Mesothelin (MSLN) is a glycoprotein expressed in the mesothelial cells of the pleura, peritoneum, and pericardium and it is reported to be highly expressed in several types of malignant tumors, including mesothelioma. This evidence concerns the gene MSLN and cancer.